Chemotherapy-related outcomes in triple-negative breast cancer.

被引：2
|
作者：
Wellmann, Rebecca M.
Ghafouri, Sanaz N.
McAndrew, Nicholas Patrick
Hurvitz, Sara A.
机构：
[1] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e12049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12049
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
    O'Shaughnessy, Joyce
    Osborne, Cynthia
    Pippen, John E.
    Yoffe, Mark
    Patt, Debra
    Rocha, Christine
    Koo, Ingrid Chou
    Sherman, Barry M.
    Bradley, Charles
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 205 - 214
  • [2] Survival outcomes across ethnicities in triple-negative breast cancer.
    Rushton, Moira Katherine
    Zhang, Tinghua
    Song, Xinni
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Epigenetic heterogeneity in triple-negative breast cancer.
    Maruyama, Reo
    Yang, Liying
    Kumegawa, Kohei
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 29 - 30
  • [4] Chronobiological assessment of triple-negative breast cancer.
    Revazishvili, Pati
    Tavartkiladze, Alexandre
    Tavartkiladze, Levan
    Sordia, Teimuraz
    Gvajaia, Ani
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    CANCER RESEARCH, 2011, 71
  • [6] Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
    Nowakowska, Malgorzata
    Lei, Xiudong
    Thompson, Mikayla R.
    Shaitelman, Simona Flora
    Wehner, Mackenzie
    Woodward, Wendy A.
    Giordano, Sharon H.
    Nead, Kevin Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Dissecting the functional landscape of triple-negative breast cancer.
    Maxfield, Kimberly
    Prat, Aleix
    Corcoran, Kathleen
    Whitehurst, Angelique
    CANCER RESEARCH, 2013, 73 (08)
  • [8] Preclinical studies with neratinib in triple-negative breast cancer.
    Mulloly, Maeve
    O'Brien, Neil A.
    Conklin, Dylan
    Finn, Richard S.
    Slamon, Dennis J.
    Crown, John
    O'Donovan, Norma
    McGowan, Patricia M.
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
    Mayer, Erica L.
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3369 - +
  • [10] Pembrolizumab plus Chemotherapy for triple-negative Breast Cancer
    Judith Lorenz, Kuenzell
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (11) : 1114 - 1114
12345